Vogt Mario H J, Lopatinskaya Luba, Smits Monique, Polman Chris H, Nagelkerken Lex
Division of Immunological and Infectious Diseases, TNO Prevention and Health, Leiden, The Netherlands.
Ann Neurol. 2003 Jun;53(6):819-22. doi: 10.1002/ana.10606.
In the search for proteins that might play a role in the pathogenesis of multiple sclerosis (MS), osteopontin (OPN) has been identified as the most prominent cytokine-encoding gene expressed within MS lesions. Here, we report significantly increased OPN protein levels in plasma of relapsing-remitting MS patients. In contrast, OPN protein levels in primary progressive and secondary progressive MS patients were similar to healthy control levels. Interestingly, active relapsing-remitting patients had higher OPN protein levels than patients without relapses.
在寻找可能在多发性硬化症(MS)发病机制中起作用的蛋白质时,骨桥蛋白(OPN)已被确定为MS病灶内表达最显著的细胞因子编码基因。在此,我们报告复发缓解型MS患者血浆中OPN蛋白水平显著升高。相比之下,原发性进展型和继发性进展型MS患者的OPN蛋白水平与健康对照水平相似。有趣的是,复发缓解型活动期患者的OPN蛋白水平高于无复发患者。